SBFI26 induces triple‐negative breast cancer cells ferroptosis via lipid peroxidation
Gang He,
No information about this author
Yiyuan Zhang,
No information about this author
Yanjiao Feng
No information about this author
et al.
Journal of Cellular and Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
28(7)
Published: March 22, 2024
Abstract
SBFI26,
an
inhibitor
of
FABP5,
has
been
shown
to
suppress
the
proliferation
and
metastasis
tumour
cells.
However,
underlying
mechanism
by
which
SBFI26
induces
ferroptosis
in
breast
cancer
cells
remains
largely
unknown.
Three
cell
lines
were
treated
with
CCK‐8
assessed
cytotoxicity.
Transcriptome
was
performed
on
Illumina
platform
verified
qPCR.
Western
blot
evaluated
protein
levels.
Malondialdehyde
(MDA),
total
superoxide
dismutase
(T‐SOD),
Fe,
glutathione
(GSH)
oxidized
(GSSG)
measured.
induced
death
time‐
dose‐dependent,
a
more
significant
inhibitory
effect
MDA‐MB‐231
Fer‐1,
GSH
Vitamin
C
attenuated
effects
but
not
erastin.
RNA‐Seq
analysis
revealed
that
treatment
significantly
enriched
differentially
expressed
genes
related
ferroptosis.
Furthermore,
increased
intracellular
MDA,
iron
ion,
GSSG
levels
while
decreasing
T‐SOD,
(T‐GSH),
levels.SBFI26
dose‐dependently
up‐regulates
expression
HMOX1
ALOX12
at
both
gene
levels,
promoting
Similarly,
it
increases
SAT1,
ALOX5,
ALOX15,
ALOXE3
CHAC1
that,
downregulating
NFE2L2
inhibit
leads
cellular
accumulation
fatty
acids,
triggers
excess
ferrous
ions
subsequent
lipid
peroxidation
for
inducing
Language: Английский
Ferroptosis of T cell in inflammation and tumour immunity
Clinical and Translational Medicine,
Journal Year:
2025,
Volume and Issue:
15(3)
Published: March 1, 2025
Ferroptosis
is
an
innovative
concept
defined
as
a
distinct
programmed
cell
death
mode
regulated
by
iron-dependent
lipid
peroxidation
accumulation.
This
process
governed
numerous
energy
metabolites
such
fatty
acids,
amino
acids
and
glucose,
well
iron
homeostasis.
In
recent
years,
increasing
studies
have
been
devoted
to
the
crucial
effects
of
ferroptosis
in
immune
cells
during
pathogenesis
diseases
infections,
tumours
autoimmune
disorders.
review
summarises
latest
advancements
T-cell
ferroptosis,
addresses
key
components
mechanism
T
inflammatory
conditions
tumour
progression,
highlights
potential
target
for
treating
related
diseases.
KEY
POINTS:
Ferroptosis-related
mechanisms
significantly
affect
biology
CD4+
subsets
are
further
involved
Crosstalk
between
CD8+
induces
microenvironment.
Glutathione
peroxidase
4
loss
promotes
regulatory
enhance
anti-tumour
immunity.
Language: Английский
USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC
Jiaxin Qian,
No information about this author
Zitong Zhao,
No information about this author
Liying Ma
No information about this author
et al.
Clinical & Translational Oncology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 10, 2025
Language: Английский
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan,
No information about this author
Shuaikang Pan,
No information about this author
Benjie Shan
No information about this author
et al.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: March 3, 2025
Aberrant
lipid
metabolism
is
a
well-recognized
hallmark
of
cancer.
Notably,
breast
cancer
(BC)
arises
from
lipid-rich
microenvironment
and
depends
significantly
on
metabolic
reprogramming
to
fulfill
its
developmental
requirements.
In
this
review,
we
revisit
the
pivotal
role
in
BC,
underscoring
impact
progression
tumor
microenvironment.
Firstly,
delineate
overall
landscape
highlighting
roles
patient
prognosis.
Given
that
lipids
can
also
act
as
signaling
molecules,
next
describe
exchanges
between
BC
cells
other
cellular
components
Additionally,
summarize
therapeutic
potential
targeting
aspects
processes,
lipid-related
transcription
factors
immunotherapy
BC.
Finally,
discuss
possibilities
problems
associated
with
clinical
applications
lipid‑targeted
therapy
propose
new
research
directions
advances
spatiotemporal
multi-omics.
Language: Английский
Iron-Dependent Cell Death: Exploring Ferroptosis as a Unique Target in Triple-Negative Breast Cancer Management
L. Tan,
No information about this author
Jiaxing Liu,
No information about this author
C Ma
No information about this author
et al.
Cancer Management and Research,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 625 - 637
Published: March 1, 2025
Triple-negative
breast
cancer
(TNBC)
is
characterized
by
aggressive
behavior,
high
metastatic
potential,
and
frequent
relapses,
presenting
significant
treatment
challenges.
Ferroptosis,
a
unique
form
of
programmed
cell
death
marked
iron-dependent
lipid
peroxidation,
has
emerged
as
crucial
factor
in
biology.
Recent
studies
indicate
that
TNBC
cells
possess
distinct
metabolic
profile
linked
to
iron
glutathione,
which
may
render
them
more
susceptible
ferroptosis
than
other
subtypes.
Moreover,
plays
role
the
interactions
between
immune
tumor
cells,
suggesting
its
potential
modulate
microenvironment
influence
response
against
TNBC.Evidence
reveals
not
only
affects
viability
but
also
alters
promoting
release
damage-associated
molecular
patterns
(DAMPs),
can
recruit
site.
Specific
ferroptosis-related
genes
biomarkers,
such
ACSL4
GPX4,
demonstrate
altered
expression
tissues,
offering
promising
avenues
for
diagnostic
prognostic
applications.
Furthermore,
preclinical
models,
induction
been
shown
enhance
efficacy
existing
therapies,
indicating
synergistic
effect
could
be
harnessed
therapeutic
benefit.
The
compelling
link
underscores
novel
target.
Future
research
should
focus
on
developing
strategies
exploit
conjunction
with
traditional
including
identification
natural
compounds
efficacious
inducers
personalized
regimens.
This
review
elucidates
multifaceted
implications
TNBC,
providing
valuable
insights
improving
both
diagnosis
this
formidable
subtype.
Language: Английский
Study on heparanase promoting breast cancer cell proliferation and inhibiting NK cell cytolytic activity via the PD-1/PD-L1 pathway
Clinical Breast Cancer,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Language: Английский
[Experimental study on promotion of peripheral nerve regeneration by selenium-methylselenocysteine].
Jianguo Song,
No information about this author
Haodong Lin
No information about this author
PubMed,
Journal Year:
2024,
Volume and Issue:
38(5), P. 598 - 607
Published: May 15, 2024
To
investigate
the
feasibility
of
selenium-methylselenocysteine
(SMC)
to
promote
peripheral
nerve
regeneration
and
its
mechanism
action.
Language: Английский
Targeting ferroptosis reveals a new strategy for breast cancer treatment: a bibliometric study
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Nov. 19, 2024
Studies
exploring
the
role
of
ferroptosis
in
pathogenesis
breast
cancer
have
proliferated
over
past
decade,
especially
2023,
with
a
staggering
217
publications
related
studies.
However,
there
are
still
significant
gaps
comprehensive
scientometric
analysis
and
mapping
scientific
studies,
terms
temporal
study
area
tracking,
principal
investigators,
emergence
new
hotspots.
This
aims
to
summarize
development
latest
research
results
on
ferroptosis-targeted
treatment
use
bibliometric
methods
draw
visual
map
explore
future
trends.
On
May
11,
2024,
this
updated
progress
11
years
by
retrieving
data
from
January
1,
2014,
Web
Science
database.
In
research,
many
software
including
VOSviewer,
chorddiag
R
Language
Pack,
Scimago
Graphica,
Citespace
6.3.R1,
Cluster
Profiler,
enrichplot,
ggplot2
Cytoscape,
STRING
online
platform
used
make
in-depth
visualization
measurement
results.
Statistical
these
showed
that
China
accounted
for
74.43%
total
publications,
highlighting
China's
dominant
relationship
between
cancer.
Several
institutions,
Sun
Yat-sen
University,
Zhejiang
Shanghai
Jiao
Tong
achieved
impressive
Efferth,
Thomas
is
most
prominent
author
field
has
highest
number
subfield
oncology.
clearly
shows
plays
crucial
triple-negative
cancer,
hepatocellular
carcinoma,
glioma,
leukemia,
mitochondrial
disease,
lymphoma,
bladder
tumors,
lung
adenocarcinoma,
esophageal
tumors.
provides
evaluation
deepens
our
understanding
current
status
targeting
treating
Thus,
it
helps
researchers
fields
directions
comprehensively
extracting
important
information
Language: Английский
Identification of key genes to predict response to chemoradiotherapy and prognosis in esophageal squamous cell carcinoma
Frontiers in Molecular Biosciences,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 20, 2024
Chemoradiotherapy
is
a
crucial
treatment
modality
for
esophageal
squamous
cell
carcinoma
(ESCC).
This
study
aimed
to
identify
chemoradiotherapy
sensitivity-related
genes
and
analyze
their
prognostic
value
potential
associations
with
the
tumor
microenvironment
in
ESCC.
Language: Английский